Illumina $750 million revolving credit facility
Davis Polk advised the agents and joint lead arrangers in connection with a $750 million unsecured revolving credit facility for Illumina, Inc. The proceeds of the loans will be used to finance working capital needs and for general corporate purposes.
Based in San Diego, California, Illumina is the global leader in sequencing- and array-based solutions for genetic analysis. Its products and services serve customers in a wide range of markets, enabling the adoption of genomic solutions in research and clinical settings. Illumina’s common stock is listed on the Nasdaq Global Select Market under the symbol “ILMN.”